Narjust Florez: Special episode of Lung Cancer Considered about WCLC24
Narjust Florez posted on X:
“We have an incredible and innovative program for WCLC24 that is patient centered with clinical pearls throughout the program.
What to learn more about our upcoming World Conference on Lung Cancer?
Check this special episode of Lung Cancer Considered.”
Source: Narjust Florez/X
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023